- Home
- SNN vs RVTY Comparison
SNN vs RVTY Comparison
Compare SNN & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNN | RVTY |
|---|---|---|
| Founded | 1856 | 1937 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 11.8B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | SNN | RVTY |
|---|---|---|
| Price | $32.25 | $87.12 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 15 |
| Target Price | $36.25 | ★ $113.00 |
| AVG Volume (30 Days) | 784.0K | ★ 978.4K |
| Earning Date | 03-02-2026 | 04-27-2026 |
| Dividend Yield | ★ 2.32% | 0.32% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $7.19 | $6.34 |
| Revenue Next Year | $5.36 | $5.10 |
| P/E Ratio | $64.97 | ★ $42.45 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.91 | $81.36 |
| 52 Week High | $38.79 | $118.30 |
Technical Indicators
Market Signals| Indicator | SNN | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 36.88 | 38.12 |
| Support Level | $32.15 | $83.11 |
| Resistance Level | $33.89 | $88.60 |
| Average True Range (ATR) | 0.56 | 2.72 |
| MACD | -0.16 | 0.34 |
| Stochastic Oscillator | 19.91 | 38.87 |
Price Performance
Historical ComparisonAbout SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.